SCHEMBL3063385

SCHEMBL3063385

Cc1c(I)ccc(F)c1CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925138 0.79 GCGR (0.32)
SCHEMBL19682452 0.78 PKM (0.33)
SCHEMBL1561409 0.74 TAAR1 (0.36)
SCHEMBL28349911 0.72 ACHE (0.32)
SCHEMBL13212278 0.70 HDAC4 (0.33)
SCHEMBL20560228 0.70 TAAR1 (0.41)
SCHEMBL379227 0.70 ENPP2 (0.33)
SCHEMBL10472581 0.67 TAAR1 (0.32)
SCHEMBL14018110 0.67 NOTUM (0.39)
SCHEMBL5399321 0.66 ACHE (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399507-B2 Antidiabetic tricyclic compounds MERCK SHARP & DOHME CORP. (US) 2013-03-19 US disclosed
US-8399507-B2 Antidiabetic tricyclic compounds MERCK SHARP & DOHME CORP. (US) 2013-03-19 US disclosed
US-8399507-B2 Antidiabetic tricyclic compounds MERCK SHARP & DOHME CORP. (US) 2013-03-19 US disclosed
EP-2215068-B1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME (US) 2012-06-13 EP disclosed
US-20100216694-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME LLC 2010-08-26 US disclosed
US-20100216694-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME LLC 2010-08-26 US disclosed
US-20100216694-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME LLC 2010-08-26 US disclosed
WO-2009058237-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK & CO., INC. (US) 2009-05-07 WO disclosed